Division of Endocrinology at Weill Cornell Medicine, Comprehensive Weight Control Center, 1165 York Avenue, New York, NY 10021, USA.
Division of Endocrinology at Weill Cornell Medicine, Comprehensive Weight Control Center, 1165 York Avenue, New York, NY 10021, USA.
Nurs Clin North Am. 2021 Dec;56(4):527-541. doi: 10.1016/j.cnur.2021.07.008.
Obesity is the most significant risk factor for the development of diabetes. Both obesity and diabetes rates have continued to increase in tandem and pose increased mortality for patients and increased health care costs for the community. Weight loss of 5% or more of total body weight renders improvements in glycemic control, decreases in the need for diabetes medications, and improved quality of life. Cotreatment of obesity and diabetes requires a comprehensive medical approach that encompasses intensive lifestyle modification including behavioral changes, nutrition, and physical activity, as well as pharmacotherapy and possible surgical management.
肥胖是糖尿病发展的最重要危险因素。肥胖和糖尿病的发病率一直在同步上升,这增加了患者的死亡率,并增加了社区的医疗保健成本。体重减轻 5%或更多的总体重可改善血糖控制,减少对糖尿病药物的需求,并提高生活质量。肥胖和糖尿病的共同治疗需要综合医疗方法,包括强化生活方式改变,包括行为改变、营养和身体活动,以及药物治疗和可能的手术管理。